|
AUPH Aurinia Pharmaceuticals Inc 1600620 |
| Balance Sheet |
|
Current Assets
|
$480,244,000.00 |
|
Assets
|
$723,997,000.00 |
|
Current Liabilities
|
$86,556,000.00 |
|
Liabilities
|
$156,371,000.00 |
|
Equity
|
$567,626,000.00 |
|
Shares Out
|
130771000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$32,560,000.00 |
|
Investing Cash Flow
|
$-18,080,000.00 |
| Market Analysis |
Market Cap
|
$1,961,565,000.00 |
|
Price
|
$14.64 |
|
BVPS
|
4.34 |
|
PB
|
3.46 |
|
EPS
|
0.26 |
|
PE
|
7.95 |
|
PS
|
6.57 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:18 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
1.53 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
0.25 |
|
| Jul |
Aug |
Sep |
|
|
2025-07-31 |
0.16 |
|
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
0.23 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AUPH documents filed with the SEC.
AUPH Filings
Clear
